Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies
Clinical trial NCT07335328 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07335328
- Sponsor
- Medical College of Wisconsin
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2027-05-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.